留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

应中央军委要求,2022年9月起,《药学实践杂志》将更名为《药学实践与服务》,双月刊,正文96页;2023年1月起,拟出版月刊,正文64页,数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿!

盐霉素钠纳米脂质体的制备及表征

巩志荣 何文婷 孙治国 郭海霞 钟延强 鲁莹

巩志荣, 何文婷, 孙治国, 郭海霞, 钟延强, 鲁莹. 盐霉素钠纳米脂质体的制备及表征[J]. 药学实践与服务, 2015, 33(1): 36-39,43. doi: 10.3969/j.issn.1006-0111.2015.01.009
引用本文: 巩志荣, 何文婷, 孙治国, 郭海霞, 钟延强, 鲁莹. 盐霉素钠纳米脂质体的制备及表征[J]. 药学实践与服务, 2015, 33(1): 36-39,43. doi: 10.3969/j.issn.1006-0111.2015.01.009
GONG Zhirong, HE Wenting, SUN Zhiguo, GUO Haixia, ZHONG Yanqiang, LU Ying. Preparation and characterization of salinomycin sodium loaded nano liposomes[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(1): 36-39,43. doi: 10.3969/j.issn.1006-0111.2015.01.009
Citation: GONG Zhirong, HE Wenting, SUN Zhiguo, GUO Haixia, ZHONG Yanqiang, LU Ying. Preparation and characterization of salinomycin sodium loaded nano liposomes[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(1): 36-39,43. doi: 10.3969/j.issn.1006-0111.2015.01.009

盐霉素钠纳米脂质体的制备及表征

doi: 10.3969/j.issn.1006-0111.2015.01.009

Preparation and characterization of salinomycin sodium loaded nano liposomes

  • 摘要: 目的 制备并表征盐霉素钠纳米脂质体(SLN)。 方法 采用薄膜分散法制备盐霉素钠纳米脂质体,通过调节脂质体中胆固醇比例,以盐霉素钠包封率为评价指标,筛选盐霉素钠纳米脂质体的优化处方。 结果 透射电镜显示盐霉素钠纳米脂质体形态圆整,分散性良好,激光粒度仪显示盐霉素钠纳米脂质体平均粒径为99.0 nm,Zeta电位为-33.5 mV,包封率为85.7%,载药量为6.7%。通过脂质体包裹,盐霉素钠在水中的最高浓度可提高15倍,并证明其具有一定缓释效果。 结论 笔者得到了粒径大小在100 nm左右,形态均一,包封率和载药量较高的盐霉素钠纳米脂质体,为进一步测定其杀伤肿瘤活性奠定了坚实的制剂学基础。
  • [1] Reya T,Morrison SJ,Clarke MF,et al.Stem cells,cancer,and cancer stem cells[J].Nature,2001,414(6859):105-111.
    [2] Dean M,Fojo T,Bates S.Tumour stem cells and drug resistance[J].Nat Rev Cancer,2005,5(4):275-284.
    [3] Gupta PB,Onder TT,Jiang G,et al.Identification of selective inhibitors of cancer stem cells by high-throughput screening[J].Cell,2009,138(4):645-659.
    [4] Naujokat C,Steinhart R.Salinomycin as a drug for targeting human cancer stem cells[J].Biomed Res Int,2012,2012:1-17.
    [5] Huczynski A.Salinomycin:a new cancer drug candidate[J].Chem Biol Drug Des,2012,79(3):235-238.
    [6] Liu Y,Miyoshi H,Nakamura M.Nanomedicine for drug delivery and imaging:a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles[J].Int J Cancer,2007,120(12):2527-2537.
    [7] Chang H,Yeh M.Clinical development of liposome-based drugs:formulation,characterization,and therapeutic efficacy[J].Int J Nanomed,2012,7:49-60.
    [8] Barenholz YC.Doxil -the first FDA-approved nano-drug:lessons learned[J].J Control Release,2012,160(2):117-134.
    [9] Farokhzad OC,Langer R.Nanomedicine:developing smarter therapeutic and diagnostic modalities[J].Adv Drug Deliver Rev,2006,58(14):1456-1459.
    [2] Mayer LD,Hope MJ,Cullis PR.Vesicles of variable sizes produced by a rapid extrusion procedure[J].BBA-Biomembranes 1986,858(1):161-168.
    [3] Mayer LD,Harasym TO,Tardi PG,et al.Ratiometric dosing of anticancer drug combinations:controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice[J].Mol Cancer Ther,2006,5(7):1854-1863.
    [4] Damen J,Regts J,Scherphof G.Transfer and exchange of phospholipid between small unilamellar liposomes and rat plasma high density lipoproteins Dependence on cholesterol content and phospholipid composition[J].Biochim Biophys Acta,1981,665(3):538-545.
    [5] 朱会琴, 逄涣欢,胡昌勤,等.浊度法测定两性霉素B及其脂质体的效价[J].中国抗生素杂志,2006,30(12):752-755.
    [6] Wong M,Chiu GN.Simultaneous liposomal delivery of quercetin and vincristine for enhanced estrogen-receptor-negative breast cancer treatment[J].Anticancer Drugs,2010,21(4):401-410.
    [7] Lasic DD,Woodle MC,Martin FJ,et al.Phase-behavior of stealth-lipid-lecithin mixtures[J].Period Biol,1991,93(2):287-290.
    [8] Dusi G,Gamba V.Liquid chromatography with ultraviolet detection of lasalocid,monensin,salinomycin and narasin in poultry feeds using pre-column derivatization[J].J Chromatogr A,1999,835(1-2):243-246.
  • [1] 宋雨桐, 夏德润, 顾珩, 唐少文, 易洪刚, 沃红梅.  帕博利珠单抗与铂类化疗方案在晚期非小细胞肺癌一线治疗中的药物经济学评价 . 药学实践与服务, 2024, 42(7): 1-7. doi: 10.12206/j.issn.2097-2024.202303023
    [2] 冯志惠, 邓仪卿, 叶冰, 安培, 张宏, 张海军.  雀梅藤石油醚提取物诱导三阴性乳腺癌细胞凋亡的实验研究 . 药学实践与服务, 2024, 42(6): 253-259. doi: 10.12206/j.issn.2097-2024.202311055
    [3] 修建平, 杨朝爱, 刘禧澳, 潘乾禹, 韦广旭, 王卫星.  全反式维甲酸对肝星状细胞活化及氧化应激的作用和机制探索 . 药学实践与服务, 2024, 42(7): 1-6. doi: 10.12206/j.issn.2097-2024.202312054
    [4] 姜涛, 徐卫凡, 蒋益萍, 夏天爽, 辛海量.  巴戟天丸组方对Aβ损伤成骨细胞的作用及基于网络药理学的机制研究 . 药学实践与服务, 2024, 42(7): 1-7. doi: 10.12206/j.issn.2097-2024.202305011
    [5] 杨媛媛, 安晓强, 许佳捷, 江键, 梁媛媛.  正极性驻极体联合5-氟尿嘧啶对瘢痕成纤维细胞生长抑制的协同作用 . 药学实践与服务, 2024, 42(6): 244-247. doi: 10.12206/j.issn.2097-2024.202310027
    [6] 史生辉, 石飞, 雷琼, 王亚峰, 吴雪花.  青藏高原肺结核合并念珠菌感染患者的病原菌分布特点及耐药率分析 . 药学实践与服务, 2024, 42(6): 260-262, 272. doi: 10.12206/j.issn.2097-2024.202304014
  • 加载中
计量
  • 文章访问数:  3228
  • HTML全文浏览量:  233
  • PDF下载量:  255
  • 被引次数: 0
出版历程
  • 收稿日期:  2014-09-27
  • 修回日期:  2014-11-16

盐霉素钠纳米脂质体的制备及表征

doi: 10.3969/j.issn.1006-0111.2015.01.009

摘要: 目的 制备并表征盐霉素钠纳米脂质体(SLN)。 方法 采用薄膜分散法制备盐霉素钠纳米脂质体,通过调节脂质体中胆固醇比例,以盐霉素钠包封率为评价指标,筛选盐霉素钠纳米脂质体的优化处方。 结果 透射电镜显示盐霉素钠纳米脂质体形态圆整,分散性良好,激光粒度仪显示盐霉素钠纳米脂质体平均粒径为99.0 nm,Zeta电位为-33.5 mV,包封率为85.7%,载药量为6.7%。通过脂质体包裹,盐霉素钠在水中的最高浓度可提高15倍,并证明其具有一定缓释效果。 结论 笔者得到了粒径大小在100 nm左右,形态均一,包封率和载药量较高的盐霉素钠纳米脂质体,为进一步测定其杀伤肿瘤活性奠定了坚实的制剂学基础。

English Abstract

巩志荣, 何文婷, 孙治国, 郭海霞, 钟延强, 鲁莹. 盐霉素钠纳米脂质体的制备及表征[J]. 药学实践与服务, 2015, 33(1): 36-39,43. doi: 10.3969/j.issn.1006-0111.2015.01.009
引用本文: 巩志荣, 何文婷, 孙治国, 郭海霞, 钟延强, 鲁莹. 盐霉素钠纳米脂质体的制备及表征[J]. 药学实践与服务, 2015, 33(1): 36-39,43. doi: 10.3969/j.issn.1006-0111.2015.01.009
GONG Zhirong, HE Wenting, SUN Zhiguo, GUO Haixia, ZHONG Yanqiang, LU Ying. Preparation and characterization of salinomycin sodium loaded nano liposomes[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(1): 36-39,43. doi: 10.3969/j.issn.1006-0111.2015.01.009
Citation: GONG Zhirong, HE Wenting, SUN Zhiguo, GUO Haixia, ZHONG Yanqiang, LU Ying. Preparation and characterization of salinomycin sodium loaded nano liposomes[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(1): 36-39,43. doi: 10.3969/j.issn.1006-0111.2015.01.009
参考文献 (8)

目录

    /

    返回文章
    返回